Given the bidirectional relationship between chronic kidney disease progression and cardiovascular events, including AF and heart failure in diabetic patients [11,12,13,14,19,32], the AGE-RAGE axis could be a therapeutic target for diabetes- or aging-related disorders, such as diabetic nephropathy in patients complicated with AF. This evidence concerns the gene AGER and diabetes mellitus.